BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37610462)

  • 1. Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation.
    Louzao M; Vargas MT; Meseguer E; Pedrote Amador B; Perez Simón JA; Mingot-Castellano ME
    Ann Hematol; 2023 Nov; 102(11):3283-3284. PubMed ID: 37610462
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim.
    Pecci A; Ragab I; Bozzi V; De Rocco D; Barozzi S; Giangregorio T; Ali H; Melazzini F; Sallam M; Alfano C; Pastore A; Balduini CL; Savoia A
    EMBO Mol Med; 2018 Jan; 10(1):63-75. PubMed ID: 29191945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
    Goldberg J
    Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene.
    Noris P; Marconi C; De Rocco D; Melazzini F; Pippucci T; Loffredo G; Giangregorio T; Pecci A; Seri M; Savoia A
    Br J Haematol; 2018 Jun; 181(5):698-701. PubMed ID: 28466964
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital amegakaryocytic thrombocytopenia-3 novel c-MPL mutations and their phenotypic correlations.
    Steinberg O; Gilad G; Dgany O; Krasnov T; Zoldan M; Laor R; Kapelushnik J; Gabriel H; Churi C; Stein J; Yaniv I; Tamary H
    J Pediatr Hematol Oncol; 2007 Dec; 29(12):822-5. PubMed ID: 18090929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in the study of thrombopoietin].
    Xu W; Yu J
    Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):635-7. PubMed ID: 9592359
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y; Jin G; Sun J; Wang X; Guo L
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of peptide thrombopoietin receptor agonist romiplostim (Nplate) in a case of primary HIV-associated thrombocytopenia.
    Aslam MI; Cardile AP; Crawford GE
    J Int Assoc Provid AIDS Care; 2014; 13(1):22-3. PubMed ID: 24036490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombopoietin and neonatal thrombocytopenia.
    Israels SJ
    Pediatr Res; 2000 Feb; 47(2):176-7. PubMed ID: 10674342
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of
    Rabbolini DJ; Chun Y; Latimer M; Kunishima S; Fixter K; Valecha B; Tan P; Chew LP; Kile BT; Burt R; Radhakrishnan K; Bird R; Ockelford P; Gabrielli S; Chen Q; Stevenson WS; Ward CM; Morel-Kopp MC
    Platelets; 2018 Dec; 29(8):793-800. PubMed ID: 29090586
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombocytopenia in patients with myelodysplastic syndromes.
    Bryan J; Jabbour E; Prescott H; Kantarjian H
    Semin Hematol; 2010 Jul; 47(3):274-80. PubMed ID: 20620439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients.
    Bose P; Hussein KK; Terrell DR; Berger D; Rice L; George JN
    Am J Hematol; 2009 Jul; 84(7):459-61. PubMed ID: 19484732
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombopoietin: tickling the HSC's fancy.
    Kim AR; Sankaran VG
    EMBO Mol Med; 2018 Jan; 10(1):10-12. PubMed ID: 29191946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombopoietin-receptor agonists for immune thrombocytopenia.
    Jansen AJ; Swart RM; te Boekhorst PA
    N Engl J Med; 2011 Dec; 365(23):2240-1. PubMed ID: 22150056
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacology and clinical application of thrombopoietin receptor agonists.
    Li C; Zheng L
    Int J Hematol; 2014 Dec; 100(6):529-39. PubMed ID: 25230815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.
    Sinisalo M; Sankelo M; Itälä-Remes M
    Leuk Lymphoma; 2011 Apr; 52(4):724-5. PubMed ID: 21323511
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
    Zang W; Wei X; Wang S; Wang D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):128-31. PubMed ID: 11877062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hereditary thrombocytopenia associated with a mutation in the MYH-9 gene. Report of one case].
    Conte G; López M; Alarcón P
    Rev Med Chil; 2018 Sep; 146(9):1074-1078. PubMed ID: 30725031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hope for treatment of thrombocytopenia.
    Schick BP
    N Engl J Med; 1994 Sep; 331(13):875-6. PubMed ID: 8078536
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombopoietin receptor agonists in hereditary thrombocytopenias.
    Rodeghiero F; Pecci A; Balduini CL
    J Thromb Haemost; 2018 Sep; 16(9):1700-1710. PubMed ID: 29956472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.